Litigation Details for CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2020)
✉ Email this page to a colleague
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-03-23 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-09-10 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Zahid Nisar Quraishi |
| Patents | 9,138,456 | ||
| Attorneys | ARNOLD B. CALMANN | ||
| Firms | Parker Poe Adams & Bernstein LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC.
The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .
Details for CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-23 | External link to document | |||
| 2020-03-23 | 50 | Order of Dismissal | for one or more claims of U.S. Patent No. 9,138,456 (“the ’456 patent”) (ECF No. 1); WHEREAS… claim for infringement of U.S. Patent No. 8,835,382 (“the ’382 patent”) and to add Mylan Laboratories…on March 23, 2020, Cubist filed a Complaint for Patent Infringement against Defendants Mylan Pharmaceuticals… 10 September 2020 3:20-cv-03168 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
